Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Peripheral Arterial Disease: Features

Case Report
Silent Coronary Ischemia in a Patient With Critical Limb Ischemia: Diagnosis and Management Using Coronary CT-Derived Fractional Flow Reserve (FFRCT)
02/22/2019
Krievins and colleagues describe the successful management of a patient with CLI and femoral pseudoaneurysm who was found to have severe silent coronary ischemia by pre-operative coronary CT angiogram and FFRCT assessment.
Krievins and colleagues describe the successful management of a patient with CLI and femoral pseudoaneurysm who was found to have severe silent coronary ischemia by pre-operative coronary CT angiogram and FFRCT assessment.
Krievins and colleagues describe...
02/22/2019
Vascular Disease Management
Case Report
Late Presentation of a Symptomatic Iliac Artery Pseudoaneurysm
10/19/2018
A case report of an 80-year-old man with a history of right common iliac artery stent angioplasty and a subsequent iliac pseudoaneurysm formation.
A case report of an 80-year-old man with a history of right common iliac artery stent angioplasty and a subsequent iliac pseudoaneurysm formation.
A case report of an 80-year-old...
10/19/2018
Vascular Disease Management
Original Research
A Multi-Center, Prospective, Post-Market Registry to Evaluate Procedural Outcomes Using the Cardiva Medical VASCADE Vascular Closure System (VCS)
09/13/2018
A study led by Craig Walker, MD, confirms the safety and efficacy of the VASCADE VCS device when used in closure of antegrade femoral access sites during peripheral endovascular interventions in the treatment of PAD.
A study led by Craig Walker, MD, confirms the safety and efficacy of the VASCADE VCS device when used in closure of antegrade femoral access sites during peripheral endovascular interventions in the treatment of PAD.
A study led by Craig Walker, MD,...
09/13/2018
Vascular Disease Management
Conference Coverage
Fully Percutaneous Femoropopliteal Bypass: First-of-its-Kind Procedure for Patients With Peripheral Artery Disease
08/28/2018
Jihad Mustapha, MD, explains how percutaneous femoropopliteal bypass, a relatively new intervention, may be a potential solution for meeting unmet needs in patients with peripheral artery disease.
Jihad Mustapha, MD, explains how percutaneous femoropopliteal bypass, a relatively new intervention, may be a potential solution for meeting unmet needs in patients with peripheral artery disease.
Jihad Mustapha, MD, explains how...
08/28/2018
Vascular Disease Management
Original Research
Facilitated Intraluminal Guidewire Passage in Femoropopliteal Occlusive Pathology: Simplified Instrumentation Technique
07/16/2018
It is estimated that CTO is present in up to 40% of patients with symptomatic PAD. Initial guidewire passage required to perform successful intervention on the atherosclerotic segment becomes more difficult with the occurrence of CTO.
It is estimated that CTO is present in up to 40% of patients with symptomatic PAD. Initial guidewire passage required to perform successful intervention on the atherosclerotic segment becomes more difficult with the occurrence of CTO.
It is estimated that CTO is...
07/16/2018
Vascular Disease Management
Case Report
Excimer Laser Atherectomy for Chronic Femoropopliteal Artery Occlusion Following Failed Femoropopliteal Bypass
07/16/2018
The prevalence of PAD has increased significantly due to increased life expectancy along with the epidemic of other cardiovascular risk factors such as diabetes, and it is estimated to soon affect ≥30% of elderly patients.
The prevalence of PAD has increased significantly due to increased life expectancy along with the epidemic of other cardiovascular risk factors such as diabetes, and it is estimated to soon affect ≥30% of elderly patients.
The prevalence of PAD has...
07/16/2018
Vascular Disease Management
Original Research
Outcomes of Patients Treated For Critical Limb Ischemia in an Outpatient Endovascular Center
06/11/2018
Critical limb ischemia is present in only about 1% to 2% of all patients with peripheral arterial disease (PAD), but it is the most severe form of PAD and is responsible for 185,000 amputations in the United States each year.
Critical limb ischemia is present in only about 1% to 2% of all patients with peripheral arterial disease (PAD), but it is the most severe form of PAD and is responsible for 185,000 amputations in the United States each year.
Critical limb ischemia is...
06/11/2018
Vascular Disease Management
Conference Coverage
The Role of Lithoplasty in Calcified Lesions: Is There Promise of Improved Results?
04/16/2018
Recent data have confirmed that an endovascular-first approach using drug-eluting technologies or endoprostheses is at least non-inferior to bypass surgery even in longer lesions. However, the major drawback of balloon angioplasty, and even...
Recent data have confirmed that an endovascular-first approach using drug-eluting technologies or endoprostheses is at least non-inferior to bypass surgery even in longer lesions. However, the major drawback of balloon angioplasty, and even...
Recent data have confirmed that...
04/16/2018
Vascular Disease Management
Case Report
Learn How Access Strategy Impacts Complex CTO Crossing
04/06/2018
Access strategy for chronic total occlusions (CTOs) is crucial in obtaining procedural success. Some access sites may have a higher complication rate or be more technically difficult to obtain; therefore, the pros and cons of the approach...
Access strategy for chronic total occlusions (CTOs) is crucial in obtaining procedural success. Some access sites may have a higher complication rate or be more technically difficult to obtain; therefore, the pros and cons of the approach...
Access strategy for chronic...
04/06/2018
Vascular Disease Management
Editor's Corner
How Can We Improve Outcomes in CLI and PAD?
03/26/2018
Dr. Walker comments on overall medical evaluation and medical therapy of patients presenting with CLI and PAD.
Dr. Walker comments on overall medical evaluation and medical therapy of patients presenting with CLI and PAD.
Dr. Walker comments on overall...
03/26/2018
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement